[go: up one dir, main page]

EA199900688A1 - Хиноксалиндионы - Google Patents

Хиноксалиндионы

Info

Publication number
EA199900688A1
EA199900688A1 EA199900688A EA199900688A EA199900688A1 EA 199900688 A1 EA199900688 A1 EA 199900688A1 EA 199900688 A EA199900688 A EA 199900688A EA 199900688 A EA199900688 A EA 199900688A EA 199900688 A1 EA199900688 A1 EA 199900688A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
preparation
chinoxalindions
compound
solvate
Prior art date
Application number
EA199900688A
Other languages
English (en)
Other versions
EA001658B1 (ru
Inventor
Алан Стоби
Элизабет Колетт Луиз Готье
Дейвид Чарльз Уэйт
Роберт Джеймс Крук
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/000995 external-priority patent/WO1997032873A1/en
Priority claimed from GBGB9715783.8A external-priority patent/GB9715783D0/en
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Priority claimed from PCT/EP1998/001275 external-priority patent/WO1998038186A1/en
Publication of EA199900688A1 publication Critical patent/EA199900688A1/ru
Publication of EA001658B1 publication Critical patent/EA001658B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Luminescent Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение предлагает по существу чистое соединение формулы (I) или его фармацевтически приемлемую соль или сольват вместе с композициями, содержащими такое соединение, применение таких соединений, способы их получения и промежуточные соединения, применяемые в получении таких соединений.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900688A 1997-02-27 1998-02-24 Хиноксалиндионы EA001658B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP1997/000995 WO1997032873A1 (en) 1996-03-09 1997-02-27 Quinoxalinediones
GBGB9715783.8A GB9715783D0 (en) 1997-02-27 1997-07-25 Quinoxalinediones
PCT/EP1998/001275 WO1998038186A1 (en) 1997-02-27 1998-02-24 Quinoxalinediones

Publications (2)

Publication Number Publication Date
EA199900688A1 true EA199900688A1 (ru) 2000-04-24
EA001658B1 EA001658B1 (ru) 2001-06-25

Family

ID=10816496

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900688A EA001658B1 (ru) 1997-02-27 1998-02-24 Хиноксалиндионы

Country Status (13)

Country Link
US (1) US6333326B1 (ru)
KR (1) KR100375112B1 (ru)
AP (1) AP982A (ru)
AU (1) AU723467B2 (ru)
DZ (1) DZ2437A1 (ru)
EA (1) EA001658B1 (ru)
GT (1) GT199800045A (ru)
IL (1) IL131120A0 (ru)
IS (1) IS5142A (ru)
MA (1) MA26474A1 (ru)
OA (1) OA11189A (ru)
PL (1) PL335501A1 (ru)
UA (1) UA58534C2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2409819C (en) * 2000-05-19 2009-09-15 Yamanouchi Pharmaceutical Co., Ltd. Triazole derivatives
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
EP2150248A4 (en) 2007-01-16 2011-06-29 Univ Johns Hopkins GLUTAMATE RECEPTOR ANTAGONISTS AND METHOD OF USE
WO2008143019A1 (en) 2007-05-17 2008-11-27 Semiconductor Energy Laboratory Co., Ltd. Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158846A (en) 1990-10-29 1992-10-27 Olin Corporation Electrostatic color printing system utilizing an image transfer belt
IT1243990B (it) * 1990-10-30 1994-06-28 Minnesota Mining & Mfg Procedimento per preparare prodotti del bisfenolo fluorene
RU2095352C1 (ru) * 1990-11-06 1997-11-10 Яманоути Фармасьютикал Ко., Лтд. Производное сконденсированного пиразина
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones

Also Published As

Publication number Publication date
IL131120A0 (en) 2001-01-28
MA26474A1 (fr) 2004-12-20
KR20000075717A (ko) 2000-12-26
DZ2437A1 (fr) 2003-01-11
AP982A (en) 2001-07-16
IS5142A (is) 1999-07-30
HK1025317A1 (en) 2000-11-10
KR100375112B1 (ko) 2003-03-08
EA001658B1 (ru) 2001-06-25
US6333326B1 (en) 2001-12-25
PL335501A1 (en) 2000-04-25
GT199800045A (es) 1999-08-20
AU6827998A (en) 1998-09-18
OA11189A (en) 2003-05-14
UA58534C2 (ru) 2003-08-15
AU723467B2 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
YU41199A (sh) Hinoksalindioni
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
EA200400432A1 (ru) Производные мочевины
EA200101203A1 (ru) Производные пурина
EA199900083A1 (ru) Замещенные пиридо- или пиримидосодержащие 6,6 или 6,7-бициклические производные
DK0657458T3 (da) Inhibitorer af proteinkinase-C
DK0948527T3 (da) Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
EA199700160A1 (ru) Производные индола в качестве антагонистов eaa
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
DE69330601D1 (de) Serotoninergische ergolin derivate
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
ATE282608T1 (de) Chinoxalindionen
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
EA199900688A1 (ru) Хиноксалиндионы
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
EA199800368A1 (ru) Новые промежуточные продукты и их использование для получения n,n'-мостиковых бисиндолилмалеимидов
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
EA200100069A1 (ru) Новые 19-норстероиды, галогенированные в положении 17, способ их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие
EA199800693A1 (ru) Азольные соединения с противогрибковой активностью, предназначенные для человека и животных

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU